DHHS awards $16.8M to Medical University of South Carolina for R&D, full and open competition
Contract Overview
Contract Amount: $16,880,201 ($16.9M)
Contractor: THE Medical University of South Carolina
Awarding Agency: Department of Health and Human Services
Start Date: 2002-09-15
End Date: 2010-06-30
Contract Duration: 2,845 days
Daily Burn Rate: $5.9K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 21
Pricing Type: COST NO FEE
Sector: R&D
Place of Performance
Location: CHARLESTON, CHARLESTON County, SOUTH CAROLINA, 29425
Plain-Language Summary
Department of Health and Human Services obligated $16.9 million to THE MEDICAL UNIVERSITY OF SOUTH CAROLINA for work described as: Key points: 1. Significant investment in research and development within the physical, engineering, and life sciences. 2. Full and open competition suggests a robust market and potential for competitive pricing. 3. Long contract duration (2002-2010) may indicate complex, long-term research needs. 4. The 'COST NO FEE' contract type implies the government bears the cost, with no profit margin for the contractor.
Value Assessment
Rating: fair
The 'COST NO FEE' contract type is unusual for R&D and suggests the government is covering all costs without a contractor profit. This makes direct pricing comparisons difficult without understanding the cost structure and fee arrangement.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
Full and open competition was utilized, indicating that multiple vendors had the opportunity to bid. This method generally promotes price discovery and competitive pricing, although the 'COST NO FEE' structure complicates standard price analysis.
Taxpayer Impact: The primary taxpayer impact is the direct funding of research and development activities. The 'COST NO FEE' structure means taxpayers are funding the direct costs of the work performed.
Public Impact
Supports advancements in physical, engineering, and life sciences, potentially leading to new technologies or treatments. Funding allocated to a major academic medical institution, fostering scientific innovation and education. The long-term nature of the award suggests a sustained commitment to specific research objectives.
Waste & Efficiency Indicators
Waste Risk Score: 100 / 10
Warning Flags
- Unusual 'COST NO FEE' contract type for R&D, making standard profit/fee analysis impossible.
- Long contract duration could lead to scope creep or cost overruns if not managed effectively.
- Lack of small business participation noted.
Positive Signals
- Full and open competition indicates a healthy market for these R&D services.
- Significant investment in a critical research area.
- Award to a reputable medical university.
Sector Analysis
This contract falls under Research and Development in the Physical, Engineering, and Life Sciences (NAICS 541710). Spending in this sector is crucial for innovation and technological advancement, with significant government investment aimed at scientific discovery and application.
Small Business Impact
The data indicates that small businesses were not involved in this contract (sb: false). Further analysis would be needed to determine if opportunities were missed or if the nature of the research inherently favored larger institutions.
Oversight & Accountability
The long duration of the contract (2002-2010) necessitates robust oversight to ensure research objectives are met, costs are controlled, and the 'COST NO FEE' structure is appropriately managed by the Department of Health and Human Services.
Related Government Programs
- Research and Development in the Physical, Engineering, and Life Sciences
- Department of Health and Human Services Contracting
- National Institutes of Health Programs
Risk Flags
- Contract type ('COST NO FEE') is unusual for R&D and lacks standard profit incentives.
- Long contract duration (8 years) increases risk of cost escalation and scope creep.
- No indication of small business participation.
- Limited information on specific research outcomes and their impact.
- Potential for inefficient resource allocation due to the absence of a profit motive.
Tags
research-and-development-in-the-physical, department-of-health-and-human-services, sc, dca, 10m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $16.9 million to THE MEDICAL UNIVERSITY OF SOUTH CAROLINA. See the official description on USAspending.
Who is the contractor on this award?
The obligated recipient is THE MEDICAL UNIVERSITY OF SOUTH CAROLINA.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (National Institutes of Health).
What is the total obligated amount?
The obligated amount is $16.9 million.
What is the period of performance?
Start: 2002-09-15. End: 2010-06-30.
What specific research outcomes were achieved during the 8-year period, and how do they align with the initial objectives and taxpayer investment?
The contract spanned nearly 8 years, suggesting a substantial research effort. Without specific deliverables or outcome reports, it's difficult to assess the direct return on the $16.8 million investment. The 'COST NO FEE' structure implies the focus was on covering expenses rather than incentivizing specific, high-value outcomes through profit.
How was the 'COST NO FEE' structure justified for this R&D contract, and what mechanisms were in place to prevent cost overruns or ensure efficient resource utilization?
The 'COST NO FEE' structure is atypical for R&D and warrants scrutiny. It suggests the government assumed all direct costs without a contractor profit margin. Oversight would be critical to ensure the Medical University of South Carolina diligently managed expenses and adhered to the research scope without the typical financial incentives or penalties associated with profit-driven contracts.
Given the full and open competition, what was the competitive landscape, and were there any indications that alternative approaches or contractors could have yielded better value or outcomes?
Full and open competition suggests a competitive environment existed. However, the 'COST NO FEE' aspect complicates value assessment. While competition theoretically drives efficiency, the lack of a profit motive for the contractor might alter performance dynamics. Understanding the bidding process and the specific terms offered by competitors would be necessary to fully evaluate the value achieved.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in the Physical, Engineering, and Life Sciences
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Offers Received: 21
Pricing Type: COST NO FEE (S)
Contractor Details
Parent Company: South Carolina, State of (UEI: 067006072)
Address: 171 ASHLEY AVE, CHARLESTON, SC, 06
Business Categories: Category Business, Educational Institution, Higher Education, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $3,101,679
Exercised Options: $3,101,679
Current Obligation: $16,880,201
Timeline
Start Date: 2002-09-15
Current End Date: 2010-06-30
Potential End Date: 2010-06-30 00:00:00
Last Modified: 2012-01-09
More Contracts from THE Medical University of South Carolina
- Tuberculosis Trials and Consortium — $5.6M (Department of Health and Human Services)
View all THE Medical University of South Carolina federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →